SCHEMBL2126992

SCHEMBL2126992

CC(C)(C)C1(CCCc2ccccc2Cl)CO1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.40
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
AOC3 Q16853 1/20 0.38
KCNH2 Q12809 1/20 0.38
PNMT P11086 1/20 0.34
IDO1 P14902 1/20 0.34
HTR3E A5X5Y0 1/20 0.34
HTR3B O95264 1/20 0.34
HTR3A P46098 1/20 0.34
HTR3D Q70Z44 1/20 0.34
HTR3C Q8WXA8 1/20 0.34
HTT P42858 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
CYP2A13 Q16696 1/20 0.33
PTGES2 Q9H7Z7 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8021114 0.81 IDO1 (0.38) TAAR1SLC6A2SLC6A4SLC6A3AOC3
SCHEMBL1282488 0.75 L3MBTL1 (0.48) KCNH2NPC1RAB9A
SCHEMBL2127284 0.74 SLC6A2 (0.36) TAAR1SLC6A2SLC6A4SLC6A3PNMT
SCHEMBL256701 0.70 TAAR1 (0.56) TAAR1SLC6A2SLC6A4SLC6A3AOC3
SCHEMBL19879749 0.70 KCNH2 (0.36) TAAR1SLC6A2SLC6A4SLC6A3AOC3
Chloromethane SCHEMBL27554241 0.70 LIPG (0.56) TAAR1SLC6A2SLC6A4SLC6A3AOC3
Ammonia Solution, Strong SCHEMBL9427687 0.69 TAAR1 (0.54) TAAR1SLC6A2SLC6A4SLC6A3AOC3
SCHEMBL1374203 0.69 LIPG (0.55) TAAR1SLC6A2SLC6A4SLC6A3AOC3
SCHEMBL11268767 0.69 MAPT (0.56) KDM4ENPC1RAB9A
SCHEMBL10360969 0.69 KCNA3 (0.47) SLC6A2SLC6A4SLC6A3KCNH2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108422-A1 Antifungal 1,2,4-triazolyl Derivatives BASF SE (DE) 2012-05-03 US disclosed
EP-2443097-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2012-04-25 EP disclosed
WO-2010146111-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108422-A1 Antifungal 1,2,4-triazolyl Derivatives ERG28, CYP51A1, DPM1 TAAR1 3333/4885SLC6A2 4204/4885SLC6A4 2556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.